METHYLPHENIDATE HYDROCHLORIDE in Canada
103 medicine records from 17 holders carry this name in the official sources. Collected on November 11, 2026.
Medicines
| Name | Holder | Status | Code |
|---|---|---|---|
| AA-METHYLPHENIDATE SR · 20 MG · TABLET (EXTENDED-RELEASE) | AA PHARMA INC | authorised |
DIN
02266687DPD drug code
75209
|
| ACT METHYLPHENIDATE ER · 18 MG · TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | authorised |
DIN
02441934DPD drug code
92630
|
| ACT METHYLPHENIDATE ER · 27 MG · TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | authorised |
DIN
02441942DPD drug code
92631
|
| ACT METHYLPHENIDATE ER · 36 MG · TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | authorised |
DIN
02441950DPD drug code
92632
|
| ACT METHYLPHENIDATE ER · 54 MG · TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | authorised |
DIN
02441969DPD drug code
92633
|
| APO-METHYLPHENIDATE · 10 MG · TABLET | APOTEX INC | authorised |
DIN
02249324DPD drug code
73416
|
| APO-METHYLPHENIDATE · 20 MG · TABLET | APOTEX INC | authorised |
DIN
02249332DPD drug code
73417
|
| APO-METHYLPHENIDATE · 5 MG · TABLET | APOTEX INC | authorised |
DIN
02273950DPD drug code
75941
|
| APO-METHYLPHENIDATE CR · 10 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02559404DPD drug code
106256
|
| APO-METHYLPHENIDATE CR · 15 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02559412DPD drug code
106257
|
| APO-METHYLPHENIDATE CR · 20 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02559420DPD drug code
106258
|
| APO-METHYLPHENIDATE CR · 30 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02559439DPD drug code
106259
|
| APO-METHYLPHENIDATE CR · 40 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02559455DPD drug code
106261
|
| APO-METHYLPHENIDATE CR · 50 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02559463DPD drug code
106262
|
| APO-METHYLPHENIDATE CR · 60 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02559471DPD drug code
106263
|
| APO-METHYLPHENIDATE CR · 80 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02559498DPD drug code
106264
|
| APO-METHYLPHENIDATE ER · 18 MG · TABLET (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02452731DPD drug code
93914
|
| APO-METHYLPHENIDATE ER · 27 MG · TABLET (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02452758DPD drug code
93915
|
| APO-METHYLPHENIDATE ER · 36 MG · TABLET (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02452766DPD drug code
93916
|
| APO-METHYLPHENIDATE ER · 54 MG · TABLET (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02330377DPD drug code
81611
|
| BAR-METHYLPHENIDATE HCL CR · 10 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02484927DPD drug code
97520
|
| BAR-METHYLPHENIDATE HCL CR · 15 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02484900DPD drug code
97518
|
| BAR-METHYLPHENIDATE HCL CR · 20 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02484919DPD drug code
97519
|
| BAR-METHYLPHENIDATE HCL CR · 30 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02484935DPD drug code
97521
|
| BAR-METHYLPHENIDATE HCL CR · 40 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02484943DPD drug code
97522
|
| BAR-METHYLPHENIDATE HCL CR · 50 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02484951DPD drug code
97523
|
| BAR-METHYLPHENIDATE HCL CR · 60 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02484978DPD drug code
97525
|
| BAR-METHYLPHENIDATE HCL CR · 80 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02484986DPD drug code
97526
|
| BIPHENTIN · 10 MG · CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02277166DPD drug code
76281
|
| BIPHENTIN · 15 MG · CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02277131DPD drug code
76279
|
| BIPHENTIN · 20 MG · CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02277158DPD drug code
76280
|
| BIPHENTIN · 30 MG · CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02277174DPD drug code
76282
|
| BIPHENTIN · 40 MG · CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02277182DPD drug code
76283
|
| BIPHENTIN · 50 MG · CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02277190DPD drug code
76284
|
| BIPHENTIN · 60 MG · CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02277204DPD drug code
76285
|
| BIPHENTIN · 80 MG · CAPSULE (EXTENDED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02277212DPD drug code
76286
|
| CONCERTA · 18 MG · TABLET (EXTENDED-RELEASE) | JANSSEN INC | authorised |
DIN
02247732DPD drug code
72012
|
| CONCERTA · 27 MG · TABLET (EXTENDED-RELEASE) | JANSSEN INC | authorised |
DIN
02250241DPD drug code
73505
|
| CONCERTA · 36 MG · TABLET (EXTENDED-RELEASE) | JANSSEN INC | authorised |
DIN
02247733DPD drug code
72013
|
| CONCERTA · 54 MG · TABLET (EXTENDED-RELEASE) | JANSSEN INC | authorised |
DIN
02247734DPD drug code
72014
|
| FOQUEST · 100 MG · CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02470357DPD drug code
95933
|
| FOQUEST · 25 MG · CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02470292DPD drug code
95927
|
| FOQUEST · 35 MG · CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02470306DPD drug code
95928
|
| FOQUEST · 45 MG · CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02470314DPD drug code
95929
|
| FOQUEST · 55 MG · CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02470322DPD drug code
95930
|
| FOQUEST · 70 MG · CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02470330DPD drug code
95931
|
| FOQUEST · 85 MG · CAPSULE (CONTROLLED-RELEASE) | ELVIUM LIFE SCIENCES | authorised |
DIN
02470349DPD drug code
95932
|
| JORNAY PM · 100 MG · CAPSULE (DELAYED- AND EXTENDED-RELEASE) | KNIGHT THERAPEUTICS INC. | authorised |
DIN
02553023DPD drug code
104199
|
| JORNAY PM · 20 MG · CAPSULE (DELAYED- AND EXTENDED-RELEASE) | KNIGHT THERAPEUTICS INC. | authorised |
DIN
02553074DPD drug code
104203
|
| JORNAY PM · 40 MG · CAPSULE (DELAYED- AND EXTENDED-RELEASE) | KNIGHT THERAPEUTICS INC. | authorised |
DIN
02553066DPD drug code
104202
|
Need this list in your own system?
Every record on this page is available through the API, with its source, licence and retrieval date.